Medicated Skin Care in Germany

July 2012 | 43 pages | ID: M808954B008EN
Euromonitor International Ltd

Abstracts

Medicated skin care enjoyed the seventh successive year of positive value growth in Germany (in current terms) and saw sales grow by almost 2% to €445 million in 2011. The trend towards self-medication continued to strengthen, and was fuelled by many factors. An increasing number of consumers consider problems of this nature to be less severe and thus more appropriately treated without visiting a doctor (and a pharmacist can also be called on to provide advice), while for others there are time...

Euromonitor International's Medicated Skin Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

MEDICATED SKIN CARE IN GERMANY

Euromonitor International
July 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Bayer Vital GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 1 Bayer Vital GmbH: Key Facts
  Summary 2 Bayer Vital GmbH: Operational Indicators
Company Background
Production
  Summary 3 Bayer Vital GmbH: Production Statistics 2011
Competitive Positioning
  Summary 4 Bayer Vital GmbH: Competitive Position 2011
GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 5 GlaxoSmithKline GmbH & Co KG: Key Facts
  Summary 6 GlaxoSmithKline GmbH & Co KG: Operational Indicators
Company Background
Production
  Summary 7 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011
Competitive Positioning
  Summary 8 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011
Hexal AG in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 9 Hexal AG: Key Facts
  Summary 10 Hexal AG: Operational Indicators
Company Background
Production
  Summary 11 Hexal AG: Production Statistics 2011
Competitive Positioning
  Summary 12 Hexal AG: Competitive Position 2011
Johnson & Johnson GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 13 Johnson & Johnson GmbH: Key Facts
  Summary 14 Johnson & Johnson GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 15 Johnson & Johnson GmbH: Competitive Position 2011
Mann Chem-pharm Fabrik Gmbh, Dr Gerhard in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 16 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Key Facts
  Summary 17 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 18 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Competitive Position 2011
Novartis Consumer Health GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 19 Novartis Consumer Health GmbH: Key Facts
  Summary 20 Novartis Deutschland GmbH: Operational Indicators
Company Background
Production
  Summary 21 Novartis Deutschland GmbH: Production Statistics 2011
Competitive Positioning
  Summary 22 Novartis Consumer Health GmbH: Competitive Position 2011
Ratiopharm GmbH & Co in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 23 Ratiopharm GmbH & Co: Key Facts
  Summary 24 Ratiopharm GmbH & Co: Operational Indicators
Company Background
Production
  Summary 25 Ratiopharm GmbH & Co: Production Statistics 2011
Competitive Positioning
  Summary 26 Ratiopharm GmbH & Co: Competitive Position 2011
Stada Arzneimittel AG in Consumer Health (germany)
Strategic Direction
Key Facts
  Summary 27 STADA Arzneimittel AG: Key Facts
  Summary 28 STADA Arzneimittel AG: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 29 STADA Arzneimittel AG: Competitive Position 2011
Executive Summary
Consumer Health Overall Stagnating in Germany in 2011
Market Under Pressure From Healthier Diets and More Exercise
Very Fragmented Market Continues To Be Led by Bayer Vital
Consumer Healthcare Most Often Sold in Health and Beauty Retailers
Small Decline of Consumer Health Expected Over Forecast Period in Germany
Key Trends and Developments
Ongoing Relatively Favourable Economic Conditions in Germany in 2011
Demographic Changes Continue To Influence Consumer Health in Germany
Increasing Shares of Sales Through Internet Retailing in Consumer Health
Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers
Innovation Essential for Premium Brands To Thrive in Consumer Health
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
  Summary 30 OTC - Switches 2010-2011
Definitions
Sources
  Summary 31 Research Sources